• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内脏利什曼病-人类免疫缺陷病毒合并感染是印度比哈尔邦村庄层面传播增加的预测因素。

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Transmission at the Village Level in Bihar, India.

机构信息

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Erasmus Mundus Joint Master Degree, Infectious Diseases & One Health Programme, Department of Pharmacy, University of Tours, Tours, France.

出版信息

Front Cell Infect Microbiol. 2021 Mar 11;11:604117. doi: 10.3389/fcimb.2021.604117. eCollection 2021.

DOI:10.3389/fcimb.2021.604117
PMID:33777831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993201/
Abstract

BACKGROUND

Visceral leishmaniasis (VL) is on the verge of being eliminated as a public health problem in the Indian subcontinent. Although Post-kala-azar dermal leishmaniasis (PKDL) is recognized as an important reservoir of transmission, we hypothesized that VL patients co-infected with Human Immunodeficiency Virus (HIV) may also be important reservoirs of sustained leishmania transmission. We therefore investigated to what extent cases of PKDL or VL-HIV are associated with VL incidence at the village level in Bihar, India.

METHODS

VL, VL-HIV, and PKDL case data from six districts within the highly VL-endemic state of Bihar, India were collected through the Kala-Azar Management Information System for the years 2014-2019. Multivariate analysis was done using negative binomial regression controlling for year as a fixed effect and block (subdistrict) as a random effect.

FINDINGS

Presence of VL-HIV+ and PKDL cases were both associated with a more than twofold increase in VL incidence at village level, with Incidence Rate Ratios (IRR) of 2.16 (95% CI 1.81-2.58) and 2.37 (95% CI 2.01-2.81) for VL-HIV+ and PKDL cases respectively. A sensitivity analysis showed the strength of the association to be similar in each of the six included subdistricts.

CONCLUSIONS

These findings indicate the importance of VL-HIV+ patients as infectious reservoirs for , and suggest that they represent a threat equivalent to PKDL patients towards the VL elimination initiative on the Indian subcontinent, therefore warranting a similar focus.

摘要

背景

内脏利什曼病(VL)作为印度次大陆的一个公共卫生问题已接近消除。尽管皮肤利什曼病(PKDL)已被认为是传播的重要储存库,但我们假设感染人类免疫缺陷病毒(HIV)的 VL 患者也可能是持续利什曼病传播的重要储存库。因此,我们调查了印度比哈尔邦六个地区的 PKDL 或 VL-HIV 病例与村庄级 VL 发病率之间的关系。

方法

通过 Kala-Azar 管理信息系统收集了印度高度 VL 流行邦比哈尔邦六个地区的 2014 年至 2019 年的 VL、VL-HIV 和 PKDL 病例数据。使用负二项回归进行多变量分析,控制年份为固定效应和区块(分区)为随机效应。

结果

VL-HIV+和 PKDL 病例的存在均与村庄级 VL 发病率增加两倍以上相关,VL-HIV+和 PKDL 病例的发病率比(IRR)分别为 2.16(95%CI 1.81-2.58)和 2.37(95%CI 2.01-2.81)。敏感性分析表明,这种关联在纳入的六个分区中均具有相似的强度。

结论

这些发现表明 VL-HIV+患者作为感染性储存库的重要性,并表明他们对印度次大陆的 VL 消除倡议构成了与 PKDL 患者相当的威胁,因此需要类似的关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/4ef5de54e6c7/fcimb-11-604117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/d975c2bbbbca/fcimb-11-604117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/f364e82dca4d/fcimb-11-604117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/4ef5de54e6c7/fcimb-11-604117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/d975c2bbbbca/fcimb-11-604117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/f364e82dca4d/fcimb-11-604117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/512f/7993201/4ef5de54e6c7/fcimb-11-604117-g003.jpg

相似文献

1
Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Transmission at the Village Level in Bihar, India.内脏利什曼病-人类免疫缺陷病毒合并感染是印度比哈尔邦村庄层面传播增加的预测因素。
Front Cell Infect Microbiol. 2021 Mar 11;11:604117. doi: 10.3389/fcimb.2021.604117. eCollection 2021.
2
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
3
Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.印度比哈尔邦高度流行村庄内脏利什曼病、无症状感染和皮肤利什曼病后黑热病家庭传播的纵向研究
PLoS Negl Trop Dis. 2016 Dec 14;10(12):e0005196. doi: 10.1371/journal.pntd.0005196. eCollection 2016 Dec.
4
Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.印度次大陆的黑热病后皮肤利什曼病:对东南亚区域消除黑热病规划的一个威胁
PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877. doi: 10.1371/journal.pntd.0005877. eCollection 2017 Nov.
5
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.合并感染HIV的利什曼病患者的皮肤利什曼病后皮肤黏膜病变及其他皮肤病变:与免疫反应相关的临床表现综述
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014.
6
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.在印度比哈尔邦,采用20毫克/千克脂质体两性霉素B(安必素)治疗原发性内脏利什曼病后出现的黑热病后皮肤利什曼病。
PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.
7
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review.印度次大陆内脏利什曼病的传播动力学——一项系统文献综述
PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug.
8
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.定量评估卡拉巴肿后皮肤利什曼病对沙蝇的感染性。
Clin Infect Dis. 2019 Jul 2;69(2):251-258. doi: 10.1093/cid/ciy891.
9
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.通过在印度比哈尔邦实施基于卫生机构的哨点监测系统,改善黑热病病例管理。
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009598. doi: 10.1371/journal.pntd.0009598. eCollection 2021 Aug.
10
Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.推断传播树以指导针对内脏利什曼病和黑热病后皮肤利什曼病的干预措施。
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25742-25750. doi: 10.1073/pnas.2002731117. Epub 2020 Sep 24.

引用本文的文献

1
A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis - human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study.一项临床流行病学研究,评估印度黑热病高负担流行地区内脏利什曼病与人类免疫病毒(VL-HIV)合并感染患者的死亡率及健康相关生活质量的可能预测因素:一项描述性横断面研究。
BMC Infect Dis. 2025 Jul 2;25(1):887. doi: 10.1186/s12879-025-10768-y.
2
AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients.通过识别合并感染HIV患者中VL复发的危险因素进行人工智能驱动的分析。
Sci Rep. 2025 Jul 1;15(1):21067. doi: 10.1038/s41598-025-07406-7.
3

本文引用的文献

1
Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission.Post-Kala-Azar Dermal Leishmaniasis 作为内脏利什曼病传播的储主。
Trends Parasitol. 2019 Aug;35(8):590-592. doi: 10.1016/j.pt.2019.06.007. Epub 2019 Jun 29.
2
The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.米尔他福在南亚地区治疗晚期皮肤利什曼病的长期安全性和疗效:综述和荟萃分析。
PLoS Negl Trop Dis. 2019 Feb 11;13(2):e0007173. doi: 10.1371/journal.pntd.0007173. eCollection 2019 Feb.
3
Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.
Kala-azar elimination in India: reflections on success and sustainability.
印度消除黑热病:对成功与可持续性的思考
Int Health. 2025 Jul 1;17(4):416-422. doi: 10.1093/inthealth/ihaf013.
4
The development and maintenance of immunity against visceral leishmaniasis.针对内脏利什曼病免疫力的发展与维持。
Front Immunol. 2024 Dec 9;15:1486407. doi: 10.3389/fimmu.2024.1486407. eCollection 2024.
5
Inferring the regional distribution of Visceral Leishmaniasis incidence from data at different spatial scales.从不同空间尺度的数据推断内脏利什曼病发病率的区域分布。
Commun Med (Lond). 2024 Nov 20;4(1):240. doi: 10.1038/s43856-024-00659-9.
6
Visceral Leishmaniasis-Human Immunodeficiency Virus-Coinfected Patients Are Highly Infectious to Sandflies in an Endemic Area in India.内脏利什曼病-人类免疫缺陷病毒合并感染患者在印度的一个流行地区对沙蝇具有高度传染性。
J Infect Dis. 2024 Jun 14;229(6):1909-1912. doi: 10.1093/infdis/jiae156.
7
Comparison of the Diagnostic Performances of Five Different Tests in Diagnosing Visceral Leishmaniasis in an Endemic Region of Ethiopia.埃塞俄比亚一个流行地区五种不同检测方法诊断内脏利什曼病的诊断性能比较
Diagnostics (Basel). 2024 Jan 11;14(2):163. doi: 10.3390/diagnostics14020163.
8
Chronic High-Level Parasitemia in HIV-Infected Individuals With or Without Visceral Leishmaniasis in an Endemic Area in Northwest Ethiopia: Potential Superspreaders?慢性高水平寄生虫血症在艾滋病毒感染个体中,无论是否存在内脏利什曼病,在埃塞俄比亚西北部的一个流行地区:潜在的超级传播者?
Clin Infect Dis. 2024 Jul 19;79(1):240-246. doi: 10.1093/cid/ciae002.
9
Time to death and its determinant factors of visceral leishmaniasis with HIV co-infected patients during treatment period admitted at Metema hospital, Metema, Ethiopia: a hospital-based cross-sectional study design.埃塞俄比亚梅特马市梅特马医院收治的合并感染HIV的内脏利什曼病患者在治疗期间的死亡时间及其决定因素:一项基于医院的横断面研究设计
Trop Dis Travel Med Vaccines. 2023 Oct 29;9(1):18. doi: 10.1186/s40794-023-00203-y.
10
Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis.内脏利什曼病治疗后临床结局的宿主、寄生虫和药物决定因素:个体参与者数据荟萃分析方案。
BMJ Open. 2023 Oct 28;13(10):e074679. doi: 10.1136/bmjopen-2023-074679.
定量评估卡拉巴肿后皮肤利什曼病对沙蝇的感染性。
Clin Infect Dis. 2019 Jul 2;69(2):251-258. doi: 10.1093/cid/ciy891.
4
Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent.非典型利什曼病:全球视角,重点关注印度次大陆。
PLoS Negl Trop Dis. 2018 Sep 27;12(9):e0006659. doi: 10.1371/journal.pntd.0006659. eCollection 2018 Sep.
5
Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India.印度比哈尔邦卡拉阿瑟后皮肤利什曼病患者的知识、耻辱感、求医行为及其决定因素。
PLoS One. 2018 Sep 7;13(9):e0203407. doi: 10.1371/journal.pone.0203407. eCollection 2018.
6
New insights into leishmaniasis in the immunosuppressed.免疫抑制患者中利什曼病的新见解。
PLoS Negl Trop Dis. 2018 May 10;12(5):e0006375. doi: 10.1371/journal.pntd.0006375. eCollection 2018 May.
7
Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.印度次大陆的黑热病后皮肤利什曼病:对东南亚区域消除黑热病规划的一个威胁
PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877. doi: 10.1371/journal.pntd.0005877. eCollection 2017 Nov.
8
Human Competence to Transmit to and the Influence of Human Immunodeficiency Virus Infection.人类传播和人类免疫缺陷病毒感染的能力。
Am J Trop Med Hyg. 2018 Jan;98(1):126-133. doi: 10.4269/ajtmh.16-0883.
9
Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.印度比哈尔邦高度流行村庄内脏利什曼病、无症状感染和皮肤利什曼病后黑热病家庭传播的纵向研究
PLoS Negl Trop Dis. 2016 Dec 14;10(12):e0005196. doi: 10.1371/journal.pntd.0005196. eCollection 2016 Dec.
10
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.过去二十年印度黑热病后皮肤利什曼病(PKDL)病例的临床流行病学分析:一项基于医院的回顾性研究
BMC Public Health. 2015 Oct 26;15:1092. doi: 10.1186/s12889-015-2424-8.